Portfolio company
SIME Clinical AI
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an AI platform and point-of-care devices for rapid respiratory disease prediction and diagnostics in neonatal and adult intensive care units.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Siloam Vision
This company develops AI-enabled retinal imaging systems and diagnostic software for healthcare providers to detect preventable blindness in neonates and adults.
Deep Breath
This company develops AI-driven decision support systems to optimise mechanical lung ventilation settings for clinicians working in intensive care units.
Innocens
Innocens develops an artificial intelligence platform for neonatal intensive care units to detect sepsis and monitor patient deterioration for clinicians and hospitals.
StethoMe
This company provides a smart electronic stethoscope and AI-powered platform for families and healthcare professionals to monitor respiratory health at home.
U-Care Medical
This company develops artificial intelligence software for clinicians to predict and manage patient complications, such as acute kidney injury, within intensive care units.
BrightHeart
This company develops AI software for clinicians to improve the detection of congenital heart defects during routine prenatal ultrasound exams.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
BPCOmedia
This company develops a remote monitoring platform using artificial intelligence to predict and prevent respiratory exacerbations for patients with chronic obstructive pulmonary disease.
